Search Results Search Sort by RelevanceMost Recent Viewpoint Feb 2016 Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters. AMA J Ethics. 2016;18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602. Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78 Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.
Viewpoint Feb 2016 Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters. AMA J Ethics. 2016;18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602.
Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78
Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.